Antimicrob Agents Chemother

1. TRAN ND, Nguyen NTQ, Vu TTT, Diep P-H, et al
   Development and validation of a rabbit model of Pseudomonas aeruginosa hyperdynamic septic shock for preclinical drug development.
   Antimicrob Agents Chemother. 2026 Jun 15:e0193625. doi: 10.1128/aac.01936.
   

   >> Share

   
   

   
   Clin Infect Dis

2. MOHAN G, Hanrahan CF, Martinez-Amezcua P, Hoffmann CJ, et al
   Multidimensional Poverty and Implementation Reach of Household Contact Tracing for Tuberculosis in South Africa: Analysis of a Randomized Trial.
   Clin Infect Dis. 2026 Jun 17:ciag321. doi: 10.1093.
   

   >> Share

   
   

   
   HIV Med

3. MARCH-YAGUE A, Toledo D, Diaz A, Godoy P, et al
   History of sexually transmitted infections among mpox cases in the 2022 outbreak in Spain.
   HIV Med. 2026 Jun 19. doi: 10.1111/hiv.70270.
   

   >> Share

   
   
4. ALAGARATNAM J, Sempere A, Dam Nielsen S, Martinez E, et al
   Awareness and early implementation of the European AIDS Clinical Society Guidance on statin use in HIV for the primary prevention of cardiovascular disease: A cross-sectional survey of HIV clinicians in Europe.
   HIV Med. 2026 Jun 18. doi: 10.1111/hiv.70271.
   

   >> Share

   
   
5. TREVILLYAN JM, Hewagama S, Lee SJ, Attwood LO, et al
   Ankle brachial index not a reliable tool for risk assessment in people with HIV.
   HIV Med. 2026 Jun 18. doi: 10.1111/hiv.70273.
   

   >> Share

   
   
6. ALLAVENA C, Abulizi D, Blain H, Andriantsoanirina V, et al
   Comparison of four frailty scores to predict adverse health events and mortality in people living with HIV aged 70 years and more (ANRS EP 66 SEPTAVIH study).
   HIV Med. 2026 Jun 16. doi: 10.1111/hiv.70269.
   

   >> Share

   
   
7. MANYANGU GJ, Wajanga B, Desderius B, Fadhili S, et al
   Effect of dolutegravir on 'Life's Simple 7' cardiovascular risk factors: A longitudinal analysis from Tanzania.
   HIV Med. 2026 Jun 14. doi: 10.1111/hiv.70267.
   

   >> Share

   
   

   
   Immunology

8. GUARDIANI M, Tortellini E, Carraro A, Zingaropoli MA, et al
   Long-Acting Cabotegravir/Rilpivirine Reduces Immune-Activation and -Senescence in People With HIV With CMV Co-Infection.
   Immunology. 2026 Jun 16. doi: 10.1111/imm.70154.
   

   >> Share

   
   

   
   J Acquir Immune Defic Syndr

9. ISMAIL A, Njau P, Wang A, Kailembo A, et al
   Population Viral Load Suppression and Associated Factors in Tanzania: Findings From 2 Sequential Tanzania HIV Impact Surveys of 2016-2017 and 2022-2023.
   J Acquir Immune Defic Syndr. 2026;101:733-739.
   

   >> Share

   
   
10. REID MJA, Sturke R, Vorkoper S, Kanyike A, et al
    Brief Report: Closing the Implementation Gap: Prioritizing Rapid Science for Global HIV Impact.
    J Acquir Immune Defic Syndr. 2026;101:756-759.
    

    >> Share

    
    
11. LERTAMORNKITTI N, Pheerapanyawaranun C, Le ON, Nallusamy RA, et al
    Clinical Characteristics of Adolescents and Youth Living with HIV Transitioning from Pediatric to Adult Clinics Before and After 18 Years in Asia.
    J Acquir Immune Defic Syndr. 2026 Jun 12. doi: 10.1097/QAI.0000000000003914.
    

    >> Share

    
    
12. OSMAN F, Yende-Zuma N, Zewotir T, Naicker N, et al
    Comparing clinical and cytokine profiling of genital inflammation as predictors of HIV acquisition in women.
    J Acquir Immune Defic Syndr. 2026 Jun 12. doi: 10.1097/QAI.0000000000003915.
    

    >> Share

    
    
13. NICOLLS S, McClymont E, Lee M, Coutlee F, et al
    Incidence and Prevalence of Human Papillomavirus Infection to Predict Outcomes from HPV-Based Cervical Cancer Screening in Women and People with a Cervix Living with HIV.
    J Acquir Immune Defic Syndr. 2026 Jun 5. doi: 10.1097/QAI.0000000000003902.
    

    >> Share

    
    

    
    J Clin Invest

14. HOTCHKISS RS, Monneret G
    Host-directed immune therapies: a second front in the battle against sepsis.
    J Clin Invest. 2026;136:e204736.
    

    >> Share

    
    

    
    J Infect Dis

15. RIGGS PK, Honerkamp-Smith G, Meneses M, Caballero G, et al
    CMV IgG and EBV Cell-Associated DNA Independently Associate With Veterans Aging Cohort Study (VACS) Index 2.0 Scores in People With HIV on Antiretroviral Therapy.
    J Infect Dis. 2026 Jun 18:jiag310. doi: 10.1093.
    

    >> Share

    
    
16. LICHTNER M, Vita S
    CMV and EBV: a dynamic, powerful, and dangerous duo in PLWH.
    J Infect Dis. 2026 Jun 18:jiag311. doi: 10.1093.
    

    >> Share

    
    
17. LOUINE M, Dandekar R, Reddy SP, Karalius MC, et al
    Cerebrospinal fluid transcriptional immune pathways linked to survival in HIV-associated tuberculous meningitis.
    J Infect Dis. 2026 Jun 18:jiag313. doi: 10.1093.
    

    >> Share

    
    

    
    J Med Virol

18. LI W, Jin L, Qing Y, Rang Z, et al
    Evidence of Intestinal Barrier Dysfunction in Asymptomatic HIV Infection via the NLRP3/Caspase-1/GSDMD Pyroptosis Pathway.
    J Med Virol. 2026;98:e71020.
    

    >> Share

    
    

    
    J Virol

19. MORIARTY RV, Harwood OE, Johnson EP, Gardner W, et al
    CD8a+ cells suppress SIV replication without the development of mutations within MHC class-I-restricted epitopes during post-treatment control.
    J Virol. 2026 Jun 15:e0004126. doi: 10.1128/jvi.00041.
    

    >> Share

    
    

    
    N Engl J Med

20. LEE TC, Barina LA, Walls G, Goodman AL, et al
    Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia.
    N Engl J Med. 2026;394:2329-2339.
    

    >> Share

    
    

    
    PLoS One

21. BANDA-MTAULA GT, Gondwe MJ, Yongolo NM, Ferrand RA, et al
    Pathways of health care for people living with multimorbidity in two Southern African countries.
    PLoS One. 2026;21:e0351251.
    

    >> Share

    
    
22. MSOKA P, Mtenga A, Maro R, Akello R, et al
    Implementation bottlenecks of near point of care HIV viral load monitoring for children and young people in Tanzania: A Qualitative Study.
    PLoS One. 2026;21:e0351304.
    

    >> Share

    
    
23. BOURDEAU B, Bolton AT, Palomares M, Van Nuys J, et al
    "Picking the right person ... can make or break the whole deal": Development of a layperson injector selection tool for administration of home-based long-acting injectable antiretroviral therapies.
    PLoS One. 2026;21:e0351213.
    

    >> Share

    
    
24. KHAZAAL NAZAL AS, Rashid Alrashedi AM, Risan Al-Iessa LA, Ali Rabeea MAH, et al
    Structure-based pharmacophore modeling, high-throughput screening, and molecular dynamics identify a novel DrugBank-derived HIV-1 protease inhibitor.
    PLoS One. 2026;21:e0336765.
    

    >> Share

    
    
25. YANG SD, Qi F, Colwill K, Gingras AC, et al
    SARS-CoV-2 infection in female sex workers from Nairobi, Kenya early in the COVID-19 pandemic: Seroincidence and behavioural associations.
    PLoS One. 2026;21:e0327692.
    

    >> Share

    
    
26. YANG E, Kim S, Kim DH, Ahn MY, et al
    Factors associated with low-level viremia in people living with HIV: A 10-year retrospective study in South Korea.
    PLoS One. 2026;21:e0350391.
    

    >> Share

    
    
27. THAWANI A, Rambiki E, Huwa J, Gabriel L, et al
    High performance of point-of-care rapid tests for advanced HIV disease diagnosis by lay providers in Malawi: Results from a prospective diagnostic accuracy study supporting decentralized advanced HIV disease screening.
    PLoS One. 2026;21:e0340955.
    

    >> Share

    
    
28. LUBEGA JK, Twesigye P, Migisha R, Bulage L, et al
    Trends and spatial distribution of low-level viremia among Ugandan children and adolescents, 2014-2023.
    PLoS One. 2026;21:e0339549.
    

    >> Share

    
    
29. ZYAMBO C, Somwe P, Musukuma M, Mandyata C, et al
    Alcohol consumption and tobacco smoking associated with decreased antiretroviral therapy adherence among people living with HIV in Zambia: Evidence from a 2023 national NCDs/ HIV survey.
    PLoS One. 2026;21:e0345368.
    

    >> Share

    
    

    
    PLoS Pathog

30. TRUNFIO M, Caballero G, Gomez-Moreno V, Mallal SA, et al
    Central Nervous System T-cell immune architecture, and not HIV burden, tracks with cognition under long-term viral suppression.
    PLoS Pathog. 2026;22:e1014351.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

31. DHAR M, Vazquez-Rosa E, Chaubey K, Miller E, et al
    Endothelial KLF4 depletion drives age-related neurovascular dysfunction and neuropsychiatric impairment.
    Proc Natl Acad Sci U S A. 2026;123:e2426990123.
    

    >> Share

    
    

    
    Science

32. BINLEY J
    An HIV vaccine blueprint.
    Science. 2026;392:1241-1242.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share